Tilray | TRLY - Trade Debtors

Stock Price
10.72
Daily Change
-0.21 -1.92%
Monthly
-6.13%
Yearly
874.55%
Q1 Forecast
10.37

Tilray reported $121.49M in Trade Debtors for its fiscal quarter ending in March of 2025.





Trade Debtors Change Date
Acasti Pharma USD 20K 0 Sep/2025
Akebia Therapeutics USD 61.54M 27.17M Mar/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
Aurora Cannabis CAD 46.73M 7.59M Sep/2025
Avita Medical AUD 11.37M 593K Jun/2025
Canopy Growth CAD 26.86M 23.17M Sep/2025
Cronos Group USD 78.04M 17.64M Dec/2025
Dianthus Therapeutics USD 5M 4.96M Sep/2025
Divis Laboratories Ltd INR 26.28B 1.16B Sep/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
IQVIA Holdings USD 3.43B 113M Dec/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Moderna USD 184M 862M Dec/2025
Organigram Holdings CAD 64.86M 7.31M Sep/2025
Organon & Co USD 1.48B 0 Sep/2025
Revvity USD 744.67M 64.41M Dec/2025
Tectonic Therapeutic USD 0 270K Dec/2023
Tilray USD 121.49M 18.12M Mar/2025
Viatris USD 3.03B 340.3M Dec/2025
Xeris Pharmaceuticals USD 53.75M 700K Sep/2025